The Department of Health and Human Services should provide greater flexibility around health care staffing, provider resource allocation and accessibility to care, the AHA said today in a letter to the agency.

The letter outlines actions the Centers for Medicare & Services should take, including suspending several requirements; expanding the physician supervision requirement waiver; finalizing certain proposals from the Medicare physician fee schedule rule; delaying implementation of some price transparency rule provisions; and removing administrative and financial barriers to coverage for COVID-19.

Additionally, the letter urges HHS to coordinate with relevant agencies to provide necessary staffing relief for hard-hit hospitals; end drug manufacturer actions that pull critical resources from 340B hospitals; direct the Health Resources and Services Administration and other relevant agencies to encourage and use cross-training opportunities for health care workers; and coordinate an approach to support child care and other expenses to assist front-line health care workers.

Related News Articles

Headline
The Food and Drug Administration last week issued an emergency use authorization to Becton, Dickinson and Company for its sodium citrate blood specimen…
Headline
Some individuals with “long COVID” may have a disability under Section 1557 of the Affordable Care Act and other civil rights laws that entitles them to…
Headline
The Federal Emergency Management Agency Friday released an advisory on reimbursable communications and outreach expenses for nonprofit medical facilities and…
Headline
The AHA today told Senate leaders it strongly opposed “any attempt to take away previously-appropriated funding for hospitals and health systems, physicians,…
Headline
The AHA’s American Organization of Nursing Leadership affiliate, the American Nurses Association, and Johnson & Johnson this week released a report…
Headline
Pfizer Inc. today announced that the federal government has agreed to purchase an additional 200 million doses of its COVID-19 vaccine. The deal raises the…